What question did this study set out to answer?

June 19, 2026Epigenomics

Clinical diagnostic utility of MGMT promoter methylation

View Full Paper

Ask AI

Bookmark

Authors

Narrative review highlights MGMT promoter methylation's role in glioblastoma diagnosis and treatment prediction.

This review examines the clinical diagnostic utility of MGMT promoter methylation in glioblastoma and other cancers.
Conducted a narrative review focusing on the biology and clinical implications of MGMT methylation.
Discussed the methodological challenges and current understanding from relevant publications.
Explored emerging applications of MGMT methylation in other cancer types.
MGMT promoter hypermethylation correlates with better prognosis in glioblastoma patients.
Associated with improved response rates to alkylating therapy in the context of glioblastoma.
Identified as a valuable biomarker for refining diagnosis and predicting therapy response.

Ulrich Lehmann (2026) studied this question.

View Full Paper

Ask AI

Bookmark